METTL3 promotes mRNA methylation and enhances the stability of SRY-box transcription factor 2 (SOX2), increases SOX2 protein expression, and promotes the maintenance and radiation resistance of glioma stem-like cells [74]. The gene discussed is SOX2; the disease is central nervous system cancer.